July « 2015 « Science and Enterprise

Wireless System Developed to Deliver Drugs to Brain

By Alan, on July 17th, 2015%

(Arthur Toga, UCLA/NIH.gov)

17 July 2015. Engineers and medical researchers designed and tested in animals a system that implants drugs for the brain in ultra-thin optical cables, then triggers their release through wireless signals. The proof-of-concept system, developed at Washington University in St. Louis and University of Illinois in Urbana, is described in . . . → Read More: Wireless System Developed to Deliver Drugs to Brain

Genetic Engineered Variety Controls Destructive Moth

By Alan, on July 16th, 2015%

Diamondback moth (Olaf Leillinger, Wikimedia Commons)

16 July 2015. A genetically engineered diamondback moth that prevents females of the species from maturing is found in greenhouse tests to quickly control populations of this destructive pest. Results of the tests, led by biotechnology company Oxitec Ltd., appear today in the journal BMC Biology.

The . . . → Read More: Genetic Engineered Variety Controls Destructive Moth

Magnetic Nanoparticles Found to Boost Immunotherapy

By Alan, on July 16th, 2015%

Scanning electron micrograph of a human T-cell lymphocyte (National Institute of Allergy and Infectious Diseases, NIH)

15 July 2015. Researchers at Johns Hopkins University designed a process for making immunotherapy more practical as a cancer treatment by collecting cancer-fighting T-cells faster and easier with magnetic synthetic antigen nanoparticles. The team from the lab . . . → Read More: Magnetic Nanoparticles Found to Boost Immunotherapy

Univ. Research Execs See Science Economic Benefits

By Alan, on July 15th, 2015%

(skeeze, Pixabay)

15 July 2015. Senior research executives at 10 U.S. universities described the benefits of scientific research to their campuses, communities, and nation at a roundtable discussion today in Washington, D.C. The forum, organized by the Science Coalition and Association of American Universities, also described perils of uneven federal research funding as . . . → Read More: Univ. Research Execs See Science Economic Benefits

Bristol-Myers Squibb, S.C. Med School Partner on Fibrosis

By Alan, on July 15th, 2015%

Karen Lackey (Medical University of South Carolina)

15 July 2015. Medical University of South Carolina and pharmaceutical company Bristol-Myers Squibb are collaborating on drug discovery research to better understand the science behind fibrosis diseases, leading to new treatments. Financial and intellectual property aspects of the partnership were not disclosed.

Fibrosis is the growth . . . → Read More: Bristol-Myers Squibb, S.C. Med School Partner on Fibrosis

Trial Testing Respiratory Muscle Drug for ALS Patients

By Alan, on July 14th, 2015%

(Aidan Jones, Flickr)

14 July 2015. Biopharmaceutical company Cytokinetics is beginning a late-stage clinical trial of a drug designed to slow the decline of respiratory muscle functions in people with amyotrophic lateral sclerosis, or ALS, a neurodegenerative disorder. In addition, Cytokinetics, in South San Francisco, California, received a $1.5 million grant from the . . . → Read More: Trial Testing Respiratory Muscle Drug for ALS Patients

Process Adds Antimicrobial Silver Particles to Plants

By Alan, on July 14th, 2015%

(Armin Kübelbeck, CC-BY-SA, Wikimedia Commons)

14 July 2015. Engineers at North Carolina State University developed a process that adds biodegradable nanoparticles infused with silver to plant fibers that can kill a broad range of bacteria. A team from the lab of chemical engineering professor Orlin Velev, with colleagues from the U.S. Environmental Protection . . . → Read More: Process Adds Antimicrobial Silver Particles to Plants

FDA Clears Biotech Cancer Therapies for Early Trials

By Alan, on July 13th, 2015%

(Mikael Häggström, Wikimedia Commons)

13 July 2015. Biotechnology company Blueprint Medicines says U.S. Food and Drug Administration accepted new drug applications on its two lead products, clearing the way for trials with humans. The Cambridge, Massachusetts enterprise is developing cancer therapies, with its lead products targeting liver and gastrointestinal tumors.

Blueprint develops cancer . . . → Read More: FDA Clears Biotech Cancer Therapies for Early Trials

Spinal Stimulation Start-Up Wins $200K State Award

By Alan, on July 13th, 2015%

(Michael Dorausch, Flickr)

13 July 2015. PathMaker Neurosystems Inc., a developer of non-invasive devices that stimulate the spinal cord to relieve muscle weakness and paralysis, received a $200,000 award from a Massachusetts science funding agency. The grant was made by Massachusetts Life Sciences Center as part of its life sciences milestone achievement program.

Univ. of Arizona Spin-Off Licenses Cancer Therapy

By Alan, on July 10th, 2015%

(Prylarer, Pixabay)

10 July 2015. A new company spun-off from University of Arizona licensed a cancer therapy based on research by a pharmacy faculty member at the school, also the company’s founder. Synactix Pharmaceuticals Inc. in Tucson is founded by pharmacology professor Hong-yu Li and postdoctoral fellow Brendan Fett.

Li’s lab at Arizona . . . → Read More: Univ. of Arizona Spin-Off Licenses Cancer Therapy

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise